How do environmental factors influence health and disease and how does the microbiome modify phenotypes in metabolic diseases?
We will explore lessons learned from metabolomic profiling in large population studies and how this knowledge can be extrapolated to understand rare metabolic diseases.
New findings in gene regulation and epigenetic mechanisms with special focus on “diet and disease” will be discussed.
Transcriptome sequencing, next-generation newborn screening and computational modelling of inborn errors of metabolism will be explored.
The ethical aspects of new technologies with respect to the use of data, data management, genetic results and gene editing will be addressed.
In this session, we will open the stage to patients and patient organisations. How can we all work together to promote precision medicine and individualised treatments?
Never miss a deadline with our newsletter!
Join now and benefit from various services.
Download the 1st Announcement